Immunotherapy can be powerful—especially when biomarkers and tumor characteristics support it. The goal is to make immunotherapy decisions with stronger evidence and better readiness
Immunotherapy is a category of treatments that helps the immune system recognize and fight cancer.
Many immunotherapy decisions involve evaluating tumor and immune markers. The quality and availability of tissue can influence how confidently your team can assess those markers—and whether you can pursue additional testing later if needed.
Only your care team can determine fit. The purpose of better testing and preservation is to support clearer decision-making—not promises.
It depends on your clinical goals and what your doctor wants to evaluate.
Immunotherapy can be powerful—especially when biomarkers and tumor characteristics support it. The goal is to make immunotherapy decisions with stronger evidence and better readiness
Immunotherapy is a treatment that helps your own immune system fight disease.
In cancer care, it helps your body recognize and attack cancer cells.
Cancer can sometimes hide from the immune system or turn it off.
Immunotherapy works by boosting, training, or unlocking your body’s own immune defenses.
Some types help remove the “brakes” that stop immune cells from attacking, while others are designed to target cancer mutations more directly.
It does not work for every patient or every type of cancer.
When it does work, it can become a powerful part of treatment.
Many immunotherapy decisions involve evaluating tumor and immune markers. The quality and availability of tissue can influence how confidently your team can assess those markers—and whether you can pursue additional testing later if needed.
Only your care team can determine fit. The purpose of better testing and preservation is to support clearer decision-making—not promises.
It depends on your clinical goals and what your doctor wants to evaluate.
